Spansules Formulations India Private Limited

Spansules Formulations India Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24230TG2022PTC160441 Incorporated 09 March 2022 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME
Revenue · FY 2023
₹166.38 Cr
Latest filing
Net profit · FY 2023
₹6.12 Cr
Net margin 3.7%
EBITDA · FY 2023
₹9.79 Cr
EBITDA margin 5.9%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.54 Cr
Issued & subscribed
Open charges
₹33.01 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Employees · EPFO
59
Provident fund records

About Spansules Formulations India Private Limited

Data last updated:

Spansules Formulations India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 March 2022.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2022PTC160441. Its GSTIN is 36ABICS0231R1ZZ (Telangana).

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.54 Cr. It is led by directors including Rama Devi Guttikonda and Haswanth Rao Guttikonda.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Floor Mig – 57 Dharma Reddy Colony Hyder Nagar Kukatpally, Hyderabad, Telangana, India – 500072.

As per the financials filed for FY 2023, the company reported a revenue of ₹166.38 Cr. For the same year it recorded a net profit of ₹6.12 Cr (net margin 3.7%) and EBITDA of ₹9.79 Cr (EBITDA margin 5.9%).

The company has about 59 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹33.01 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 1 deal on record (1 funding round), with disclosed funding of ₹9.8 Cr; the latest was in April 2022.

Spansules Formulations India Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-09-0032587).

Company details

CIN U24230TG2022PTC160441
Registration Number 160441
Incorporation Date 09 March 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
MSME Classification MSME
Udyam Registration UDYAM-TS-09-0032587

Recognitions & Rankings of Spansules Formulations India

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-TS-09-0032587

Contact details

Spansules Formulations India Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    3rd Floor Mig – 57 Dharma Reddy Colony Hyder Nagar Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Spansules Formulations India Private Limited, buy the company report.

Comprehensive company report
Spansules Formulations India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Spansules Formulations India Private Limited

FY 2025 filings available

Spansules Formulations India Private Limited reported revenue of ₹166.38 Cr for FY 2023.

Revenue · FY 2023
₹166.38 Cr
Net profit · FY 2023
₹6.12 Cr margin 3.7%
EBITDA · FY 2023
₹9.79 Cr margin 5.9%

Financial Statement Summary

MetricsFY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹166.38 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹9.79 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.12 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22
Profitability
EBITDA Margin5.9%
Net Profit Margin3.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Spansules Formulations India Private Limited, buy the company report.

Board of directors of Spansules Formulations India Private Limited

Spansules Formulations India has 4 directors on record. No former directors are listed.

Auditor

Spansules Formulations India Private Limited is audited by RAO & SIVA ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
RAO & SIVA ASSOCIATESFY 202308643S

Shareholding

The shareholding of Spansules Formulations India Private Limited is on record for 2 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Spansules Formulations India Private Limited, buy the company report.

Charges & borrowings

Open charges
₹33.01 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹30.51 Cr
Axis Bank Limited₹2.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
14 Jul 2025101130960Hdfc Bank Limited₹1.12 CrOpen
12 Jan 2024100862495Hdfc Bank Limited₹15 LakhOpen
25 May 2023100725614Axis Bank Limited₹2.5 CrOpen
01 Oct 2022100629886Hdfc Bank Limited₹28.44 CrOpen
10 Jun 2022100595871Hdfc Bank Limited₹80.08 LakhOpen

To see the full charge records of Spansules Formulations India Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Spansules Formulations India Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹9.8 Cr; the latest was in April 2022.

Total deals
1
Funding round
1
Disclosed funding
₹9.8 Cr

Deals on record (1 of 1)

WhenDealAmountParties
Apr 2022Funding round₹9.8 CrInvestors: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Spansules Formulations India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Spansules Formulations India Private Limited has a workforce of 59 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
59
Active EPFO establishments
1
Employee growth
1.7%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2759
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23

To see the full employee and EPFO history of Spansules Formulations India Private Limited, buy the company report.

GST

Spansules Formulations India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36ABICS0231R1ZZTelanganaActive01 Apr 2022

To see the full GST registrations and return filing status of Spansules Formulations India Private Limited, buy the company report.

Recent activity

Spansules Formulations India Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Harika Rao Guttikonda was appointed as Director on 09 Mar 2022.

AGM
Spansules Formulations India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.12 Cr with Charge ID 101130960 was registered on 14 Jul 2025.
Filing
Spansules Formulations India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 100862495 was registered on 12 Jan 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.50 Cr with Charge ID 100725614 was registered on 25 May 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 28.44 Cr registered on 01 Oct 2022 with Charge ID 100629886 was modified on 21 Apr 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 28.44 Cr with Charge ID 100629886 was registered on 01 Oct 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.80 Cr with Charge ID 100595871 was registered on 10 Jun 2022.
Appointed
Harika Rao Guttikonda was appointed as Director.
Appointed
Haswanth Rao Guttikonda was appointed as Director.
Appointed
Rama Devi Guttikonda was appointed as Director.
Appointed
Venkata Subba Rao Guttikonda was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Spansules Formulations India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 March 2022 (4+ years old) and is registered under CIN U24230TG2022PTC160441.

Spansules Formulations India has 4 current directors:

The latest financial statements of Spansules Formulations India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Spansules Formulations India is 36ABICS0231R1ZZ, registered in Telangana.

The CIN (Corporate Identification Number) of Spansules Formulations India is U24230TG2022PTC160441. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Spansules Formulations India has 1 court case on record: 1 filed by the company.

Spansules Formulations India was incorporated on 09 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.

Spansules Formulations India has 1 deal on record (1 funding round), with disclosed funding of ₹9.8 Cr; the latest was in April 2022.

Harika Rao Guttikonda was appointed as Director on 09 Mar 2022. Haswanth Rao Guttikonda was appointed as Director on 09 Mar 2022. Rama Devi Guttikonda was appointed as Director on 09 Mar 2022. Spansules Formulations India has 4 board changes on record in total.

Yes, Spansules Formulations India is registered as an MSME under Udyam registration (number: UDYAM-TS-09-0032587).